DOYLE WILLIAM F Insider Trading
Get the latest insider transactions of DOYLE WILLIAM F. DOYLE WILLIAM F is Director in OptiNose, Inc. ($OPTN) and Director in Minerva Neurosciences, Inc. ($NERV) and Director in Novocure Ltd ($NVCR) and Executive Chairman in Novocure Ltd ($NVCR). Discover the current value of DOYLE WILLIAM F shares.
Address: C/O ZOETIS INC. 100 CAMPUS DRIVE FLORHAM PARK 07932NJ
DOYLE WILLIAM F is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
NVCR | NovoCure Ltd | Executive Chairman, Director | 648,993 | 4,413,152.40 |
OPTN | OptiNose, Inc. | Director | 817,225 | |
NERV | Minerva Neurosciences, Inc. | Director | 26,111 | 265,026.65 |
Insider Trading Transactions of DOYLE WILLIAM F
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 15 2021 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Option Exercise | 2.90 | 40,000 | 116,000 | 40,000 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 191.26 | 1,400 | 267,768 | 648,993 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 192.52 | 1,900 | 365,796 | 647,093 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 193.57 | 2,090 | 404,563 | 645,003 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 194.94 | 1,600 | 311,904 | 643,403 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 196.07 | 8,814 | 1,728,187 | 634,589 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 197.00 | 24,338 | 4,794,659 | 610,251 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 197.83 | 13,612 | 2,692,876 | 596,639 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 198.98 | 10,563 | 2,101,794 | 586,076 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 199.71 | 4,338 | 866,355 | 581,738 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 201.55 | 4,125 | 831,377 | 577,613 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 202.16 | 4,388 | 887,069 | 573,225 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 203.25 | 2,555 | 519,311 | 570,670 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 204.28 | 1,972 | 402,834 | 568,698 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 205.43 | 1,600 | 328,690 | 567,098 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 206.35 | 1,284 | 264,956 | 565,814 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 207.80 | 4,500 | 935,118 | 561,314 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 209.34 | 2,200 | 460,555 | 559,114 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 210.18 | 521 | 109,504 | 558,593 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 211.28 | 600 | 126,766 | 557,993 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 213.35 | 1,500 | 320,021 | 556,493 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 214.67 | 500 | 107,333 | 555,993 |
Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 216.69 | 600 | 130,016 | 555,393 |
Aug 03 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 76.39 | 896 | 68,444 | 649,062 |
Jun 12 2020 | OPTN | OptiNose, Inc. | DOYLE WILLIAM F | Director | Option Exercise | 5.65 | 14,439 | 81,580 | 14,439 |
Jun 12 2020 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Option Exercise | 3.40 | 40,000 | 136,000 | 40,000 |
May 12 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 63.73 | 31,332 | 1,996,726 | 649,958 |
May 11 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 64.77 | 58,768 | 3,806,403 | 685,419 |
May 11 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 64.74 | 30,993 | 2,006,518 | 654,426 |
May 11 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 63.84 | 58,767 | 3,751,685 | 713,193 |
May 11 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 63.50 | 31,903 | 2,025,872 | 681,290 |
May 11 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 58,768 | 0 | 58,767 |
May 11 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 58,767 | 0 | 0 |
May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 61.40 | 58,768 | 3,608,355 | 628,047 |
May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 61.40 | 58,768 | 3,608,355 | 628,047 |
May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 62.47 | 30,283 | 1,891,718 | 597,764 |
May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 62.47 | 30,283 | 1,891,718 | 597,764 |
May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 64.27 | 29,881 | 1,920,452 | 567,883 |
May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 64.27 | 29,881 | 1,920,452 | 567,883 |
May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 64.15 | 58,768 | 3,769,967 | 626,651 |
May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 64.15 | 58,768 | 3,769,967 | 626,651 |
May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 58,768 | 0 | 176,303 |
May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 58,768 | 0 | 176,303 |
May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 58,768 | 0 | 117,535 |
May 07 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 58,768 | 0 | 117,535 |
May 06 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 60.48 | 58,768 | 3,554,289 | 569,279 |
May 06 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 58,768 | 0 | 235,071 |
Mar 10 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 69.53 | 4,320 | 300,387 | 510,511 |
Mar 02 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 79.45 | 9,259 | 735,628 | 518,724 |
Mar 02 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 72.22 | 3,893 | 281,133 | 514,831 |
Mar 02 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 9,259 | 0 | 9,259 |
Jan 22 2020 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 95.00 | 133,777 | 12,708,815 | 509,465 |
Nov 26 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 96.04 | 16,223 | 1,558,057 | 643,242 |
Nov 22 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 90.36 | 149,300 | 13,490,016 | 660,165 |
Nov 22 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 91.01 | 700 | 63,707 | 659,465 |
Nov 13 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 80.11 | 29,782 | 2,385,776 | 822,683 |
Nov 13 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 81.59 | 11,118 | 907,118 | 811,565 |
Nov 13 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 82.14 | 2,100 | 172,498 | 809,465 |
Aug 01 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 0.00 | 6,002 | 0 | 852,465 |
Aug 01 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 83.30 | 10,412 | 867,320 | 10,412 |
Jul 01 2019 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Buy | 5.50 | 3,500 | 19,250 | 26,111 |
Jul 01 2019 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Buy | 5.50 | 3,500 | 19,250 | 26,111 |
Jun 13 2019 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Option Exercise | 4.50 | 20,000 | 90,000 | 20,000 |
Jun 10 2019 | OPTN | OptiNose, Inc. | DOYLE WILLIAM F | Director | Option Exercise | 6.60 | 14,439 | 95,297 | 14,439 |
Jun 10 2019 | OPTN | OptiNose, Inc. | DOYLE WILLIAM F | Director | Option Exercise | 6.60 | 14,439 | 95,297 | 14,439 |
May 31 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 53.10 | 1,900 | 100,881 | 894,563 |
May 31 2019 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Option Exercise | 5.21 | 20,000 | 104,200 | 20,000 |
May 10 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 47.37 | 31,460 | 1,490,386 | 896,463 |
May 10 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 47.56 | 115,060 | 5,472,254 | 115,060 |
May 10 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 47.56 | 35,000 | 1,664,600 | 35,000 |
May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 47.67 | 32,098 | 1,530,112 | 842,605 |
May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 48.92 | 58,768 | 2,874,931 | 901,373 |
May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 47.52 | 32,218 | 1,531,032 | 869,155 |
May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 47.62 | 58,768 | 2,798,532 | 927,923 |
May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 58,768 | 0 | 352,607 |
May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 58,768 | 0 | 293,839 |
May 07 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 48.07 | 29,038 | 1,395,915 | 815,935 |
May 07 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 48.89 | 58,768 | 2,873,168 | 874,703 |
May 07 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 58,768 | 0 | 411,375 |
May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 43.28 | 58,768 | 2,543,479 | 816,171 |
May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 45.21 | 29,966 | 1,354,643 | 786,205 |
May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 44.60 | 58,768 | 2,621,053 | 844,973 |
May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 58,768 | 0 | 528,911 |
May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 58,768 | 0 | 470,143 |
Mar 26 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 0.00 | 24,554 | 0 | 942,860 |
Mar 26 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 47.04 | 44,953 | 2,114,589 | 44,953 |
Mar 01 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 52.90 | 9,260 | 489,854 | 921,403 |
Mar 01 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 52.90 | 9,260 | 489,854 | 921,403 |
Mar 01 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 53.68 | 3,097 | 166,247 | 918,306 |
Mar 01 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 53.68 | 3,097 | 166,247 | 918,306 |
Mar 01 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 9,260 | 0 | 18,518 |
Mar 01 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 9,260 | 0 | 18,518 |
Dec 26 2018 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Buy | 6.50 | 2,000 | 13,000 | 22,611 |
Dec 26 2018 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Buy | 6.50 | 2,000 | 13,000 | 22,611 |
Dec 12 2018 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Buy | 8.00 | 2,000 | 16,000 | 16,611 |
Dec 12 2018 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Buy | 7.95 | 4,000 | 31,800 | 20,611 |
Nov 21 2018 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Buy | 8.20 | 2,000 | 16,400 | 14,611 |
Oct 15 2018 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Buy | 10.00 | 600 | 6,000 | 12,611 |
Sep 19 2018 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Buy | 10.50 | 1,800 | 18,900 | 12,011 |
Sep 19 2018 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Buy | 10.50 | 1,800 | 18,900 | 12,011 |
Sep 17 2018 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Buy | 10.50 | 2,000 | 21,000 | 10,011 |
Sep 17 2018 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Buy | 10.50 | 200 | 2,100 | 10,211 |
Sep 11 2018 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Buy | 9.88 | 4,000 | 39,520 | 4,000 |
Sep 11 2018 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Buy | 9.72 | 4,011 | 38,987 | 8,011 |
Aug 20 2018 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 0.00 | 187,787 | 0 | 438,167 |
Aug 02 2018 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Option Exercise | 7.95 | 20,000 | 159,000 | 20,000 |
Jul 18 2018 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 3.59 | 2,330 | 8,365 | 914,473 |
Jul 18 2018 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 3.59 | 2,330 | 8,365 | 0 |
Jul 02 2018 | OPTN | OptiNose, Inc. | DOYLE WILLIAM F | Director | Sell | 0.00 | 2,195,914 | 0 | 817,225 |
Jul 02 2018 | OPTN | OptiNose, Inc. | DOYLE WILLIAM F | Director | Option Exercise | 8.16 | 1,488,366 | 12,145,067 | 0 |
Jun 11 2018 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Option Exercise | 8.25 | 20,000 | 165,000 | 20,000 |
Jun 11 2018 | OPTN | OptiNose, Inc. | DOYLE WILLIAM F | Director | Option Exercise | 22.50 | 14,439 | 324,878 | 14,439 |
May 10 2018 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 28.06 | 28,756 | 806,750 | 940,795 |
May 10 2018 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 28.26 | 28,652 | 809,620 | 912,143 |
May 08 2018 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 27.89 | 28,666 | 799,552 | 998,355 |
May 08 2018 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 28.01 | 28,804 | 806,771 | 969,551 |
May 04 2018 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 0.00 | 293,840 | 0 | 1,055,540 |
May 04 2018 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 27.89 | 28,519 | 795,281 | 1,027,021 |
May 04 2018 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 293,840 | 0 | 587,679 |
Mar 01 2018 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 21.15 | 202,758 | 4,288,332 | 202,758 |
Mar 01 2018 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 27,778 | 0 | 27,778 |
Jan 24 2018 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 3.59 | 1,549 | 5,561 | 92,746 |
Jan 24 2018 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 3.59 | 1,549 | 5,561 | 0 |
Dec 12 2017 | NERV | Minerva Neurosciences, In ... | DOYLE WILLIAM F | Director | Option Exercise | 5.70 | 40,000 | 228,000 | 40,000 |
Oct 19 2017 | OPTN | OptiNose, Inc. | DOYLE WILLIAM F | Director | Buy | 0.00 | 18,803 | 0 | 18,803 |
Oct 19 2017 | OPTN | OptiNose, Inc. | DOYLE WILLIAM F | Director | Buy | 0.00 | 3,013,139 | 0 | 3,013,139 |
Oct 19 2017 | OPTN | OptiNose, Inc. | DOYLE WILLIAM F | Director | Option Exercise | 0.00 | 4,563 | 0 | 0 |
Oct 19 2017 | OPTN | OptiNose, Inc. | DOYLE WILLIAM F | Director | Option Exercise | 0.00 | 1,142 | 0 | 0 |
Oct 19 2017 | OPTN | OptiNose, Inc. | DOYLE WILLIAM F | Director | Option Exercise | 0.00 | 473 | 0 | 0 |
Oct 19 2017 | OPTN | OptiNose, Inc. | DOYLE WILLIAM F | Director | Option Exercise | 0.00 | 334 | 0 | 0 |
Oct 19 2017 | OPTN | OptiNose, Inc. | DOYLE WILLIAM F | Director | Option Exercise | 0.00 | 719,225 | 0 | 0 |
Oct 19 2017 | OPTN | OptiNose, Inc. | DOYLE WILLIAM F | Director | Option Exercise | 0.00 | 41,160 | 0 | 0 |
Oct 19 2017 | OPTN | OptiNose, Inc. | DOYLE WILLIAM F | Director | Option Exercise | 0.00 | 190,440 | 0 | 0 |
Oct 19 2017 | OPTN | OptiNose, Inc. | DOYLE WILLIAM F | Director | Option Exercise | 0.00 | 92,543 | 0 | 0 |
Jun 15 2017 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Buy | 3.59 | 6,498 | 23,328 | 91,197 |
Jun 15 2017 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Option Exercise | 3.59 | 6,498 | 23,328 | 0 |
May 04 2017 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 11.85 | 881,519 | 10,446,000 | 881,519 |
May 04 2017 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 11.85 | 881,519 | 10,446,000 | 881,519 |
May 04 2017 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 0.00 | 881,519 | 0 | 881,519 |
Mar 09 2017 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 0.00 | 19,732,767 | 0 | 43,000 |
Mar 02 2017 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 3.59 | 686,836 | 2,465,741 | 19,822,874 |
Mar 02 2017 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 7.60 | 324,440 | 2,465,744 | 19,498,434 |
Mar 02 2017 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | 3.59 | 525,618 | 1,886,969 | 20,024,052 |
Mar 02 2017 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 7.60 | 248,285 | 1,886,966 | 19,775,767 |
Mar 02 2017 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 3.59 | 686,836 | 2,465,741 | 0 |
Mar 02 2017 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | 3.59 | 525,618 | 1,886,969 | 0 |
Jan 04 2017 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | 0.00 | 2,242,664 | 0 | 0 |
May 10 2016 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Buy | 3.59 | 8,349 | 29,973 | 87,080 |
May 10 2016 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Sell | 12.59 | 2,381 | 29,977 | 84,699 |
May 10 2016 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Buy | 3.59 | 845,091 | 3,033,877 | 21,619,678 |
May 10 2016 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Sell | 12.59 | 240,976 | 3,033,888 | 21,378,702 |
May 10 2016 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Option Exercise | 3.59 | 8,349 | 29,973 | 0 |
May 10 2016 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Option Exercise | 3.59 | 845,091 | 3,033,877 | 0 |
Oct 09 2015 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Buy | 0.00 | 2,242,664 | 0 | 3,623,538 |
Oct 09 2015 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Buy | 0.00 | 17,151,049 | 0 | 20,774,587 |
Oct 09 2015 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Option Exercise | 0.00 | 2,242,664 | 0 | 0 |
Oct 09 2015 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Option Exercise | 0.00 | 453,621 | 0 | 0 |
Oct 09 2015 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Option Exercise | 0.00 | 4,590,439 | 0 | 0 |
Oct 09 2015 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Option Exercise | 0.00 | 1,598,626 | 0 | 0 |
Oct 09 2015 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Option Exercise | 0.00 | 3,380,361 | 0 | 0 |
Oct 09 2015 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Option Exercise | 0.00 | 4,849,836 | 0 | 0 |
Oct 09 2015 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Option Exercise | 0.00 | 1,121,329 | 0 | 0 |
Oct 09 2015 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Option Exercise | 0.00 | 1,156,837 | 0 | 0 |
Oct 06 2015 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Buy | 3.54 | 399,659 | 1,414,793 | 1,380,874 |
Oct 06 2015 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Option Exercise | 3.54 | 399,659 | 1,414,793 | 0 |